- February 15 Pharmacy Week in Review: Psoriasis Treatment May Help Prevent Heart Disease, Unproven Products Prompt FDA Warnings (pharmacytimes.com)
Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- Opioid prescriptions for pets surge, mirroring human crisis (reuters.com)Trends in Opioid Prescribing and Dispensing by Veterinarians in Pennsylvania (jamanetwork.com)
Many more Americans may be getting opioids for their pets, and veterinarians appear to be prescribing increasingly potent versions of these drugs to animals...The researchers examined data on opioid tablets and patches dispensed or prescribed by 134 veterinarians at an academic small-animal hospital in Philadelphia from 2007 to 2017. Over the decade, the amount of opioids used for creatures like rabbits, birds and reptiles surged 41 percent even though visits to the hospital increased by only 13 percent...
- February 1 Pharmacy Week in Review: Syphilis Increasing Among Pregnant Women, Pharmacies Offering Measles Vaccine in Outbreak Areas (pharmacytimes.com)
Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- MMV and DNDi create a response box to foster R&D for pandemic diseases (pharmaceutical-technology.com)
Medicines for Malaria Venture has collaborated with the Drugs for Neglected Disease initiative to create a pandemic response box, which contains 400 structurally diverse antibacterial, antiviral and antifungal compounds to help accelerate the discovery and development of new treatments of pandemic diseases...The response boxes are available free of charge to global researchers from universities and pharmaceutical companies. In return, researchers are expected to publicly share results from research and development based on the compounds within two years of obtaining a box...MMV chief scientific officer Dr Timothy Wells said: The pandemic response box came about in response to the need to be prepared for a future global health emergency...Open innovation is one of the keys to unlocking new potential for drug discovery and tapping into existing expertise to kickstart new research efforts...
- This Week in Managed Care: February 8, 2019 (ajmc.com)
Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network
- Drugmakers say UK could lose out on EU anti-counterfeit drugs push (reuters.com)
Drugmakers warned...that if Britain leaves the European Union without a deal next month Britons could miss out on an EU-wide system to fight counterfeit drugs that will go live on Saturday after years of British involvement in building it...Drugmakers, wholesalers and pharmacies across Europe have worked for more than four years on a system based on a shared database and tamper-proof packages with barcodes that will go live on Saturday, to fulfill the European Union’s Falsified Medicines Directive...“It would be an absolute travesty if NHS patients aren’t part of a system specifically designed to protect them. But that’s exactly what could happen in a ‘no deal’ Brexit,” Rick Greville, Director of Supply Chain at the Association of the British Pharmaceutical Industry, said in a statement by the lobby group...The European Medicines Verification System will allow dispensing pharmacists to scan drug packages and link up to a database to give patients assurance on the product’s authenticity.
- Insulin has become so expensive that this diabetic is trying to make his own (cnbc.com)
Insulin is a life-saving drug for diabetics. Since 2002, the price has more than tripled and some diabetics can’t afford it. People have died rationing their doses, and some are turning to other countries to buy it at a cheaper price...Now, there’s a team of biohackers called the Open Insulin Project in Oakland, California who are trying to make it...The project was co-founded by Anthony Di Franco. He’s a type 1 diabetic who is trying to prove there are easier, cheaper ways to make insulin rather than rely on the big manufacturers like Eli Lilly, Novo Nordisk and Sanofi.
- February 8 Pharmacy Week in Review: A Multifaceted Approach to Eliminated HCV, 3 States Report Measles Outbreaks (pharmacytimes.com)
Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- This Week in Managed Care: February 1, 2019 (ajmc.com)
Samantha DiGrande, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- Experimental phone app works with insulin pumps to control diabetes (reuters.com)Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development (liebertpub.com)
An artificial pancreas system that uses a smart phone app coupled with a glucose sensor and an insulin pump has shown promise in a preliminary trial in people with type 1 diabetes, researchers report...Currently, patients with type 1 diabetes must check their blood sugar levels throughout the day. Many use insulin pumps that deliver a set amount of the hormone to the body through a catheter 24 hours a day. But meal consumption, exercise and other factors can boost blood sugar levels or cause them to drop, and then the patient needs to adjust the amount of insulin being pumped into the body...The new app, which was tested under Food and Drug Administration protocols on six adults with type 1 diabetes, works with two different brands of pumps and two types of glucose sensors...Larger studies are needed to confirm the safety and effectiveness of the new artificial pancreas app. But a big advantage would be that it can be used on the person’s own cell phone...